- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2017
- Public Summary Document (PSD) July 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2017 PBAC Meeting - Word
Icatibant – July 2017
Icatibant: Injection 30 mg (as acetate)in 3 mL single use pre-filled syringe; Firazyr®
Last updated
27 October 2017